||||||||||A296 / Sichuan Kelun Pharma New P1 trial, Metastases: A Study of KL340399 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - May 23, 2022 P1, N=30, Not yet recruiting, Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.